© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
October 16, 2020
Patients diagnosed with neurologic disorders post-admission were less likely to be discharged home than those with events prior to, or at the time of admission.
October 09, 2020
ELP Pharma readying plans to continue to study the drug in a phase 3 trial.
September 19, 2020
Sumifilam could be the first Alzheimer treatment to improve several biomarkers.
July 24, 2020
As of February, 121 unique therapies are involved in clinical trials for Alzheimer disease, with putative disease-modifying agents targeting disease onset or progression accounting for the largest number.